NewslettersNeural Cell News CBX3 Accelerates the Malignant Progression of Glioblastoma Multiforme by Stabilizing EGFR Expression By lbeveridge - April 27, 2022 0 Researchers reported the identification of CBX3 as a potential therapeutic target for glioblastoma multiforme (GBM) and found that, CBX3 was significantly upregulated in GBM and reduced patient survival. [Oncogene] Abstract